Is Addyi just a pink Viagra?

The answer says a erectile dysfunction tablets uk lot about how medicine has struggled to imagine male and female sexuality—and how gendered assumptions continue to shape the medical interventions we have today.

Viagra solves a plumbing problem, pumping blood to the penis until it swells, like blowing up a balloon. Addyi, by contrast, works on the brain, adjusting levels of neurotransmitters, like dopamine and serotonin. While the drug was initially explored as an alternative antidepressant, it instead showed a promising secondary effect in women: it seemed to boost low desire, defined as a troubling lack of spontaneous thoughts and fantasies about sex. In other words, Viagra gets the juices flowing; Addyi, ostensibly, generates the fantasies. “In no way is there really a similarity, except that they both treat a type of sexual dysfunction,” said Clayton. (Clayton, who appears in the film, has consulted for numerous pharmaceutical companies. I was also listed as a consultant on the film, as was my book Vagina Obscura, but I had no part in the narrative.) In biological terms, Viagra is an arousal drug; Addyi is a desire drug. Desire is the match; arousal is the flame. Think of it like this: When you crave a birthday cake—imagining the funfetti frosting melting on your tongue—that’s desire. When your mouth waters and your stomach gurgles in response, that’s arousal.

What does this approval mean for other women’s health products?

The first medical therapy approved for pain with intercourse in menopausal women is Osphena. It is an intriguing medication as it has bone health benefits against osteopenia, and decreases risk of breast cancer. Testosterone use for women can be important for strength, moods, fatigue, as well as for sex enhancement, has been tested in many forms, some of which are still in development stages and some look more promising than others, including, testosterone patches, gels, implants, and intranasal (male intranasal is approved), Tefina still in studies, and it can be used systemically or topically, depending on the condition you want to treat. The newest libido medication to be approved is Vylessi. You cannot take it if you have high blood pressure, heart problems, kidney problems, liver problems.or are pregnant.

The Evidence Is Underwhelming at Best

It can be taken when you want it, it is an injection, and you can take it several times a month. If you have problems with Vaginal improvement, vaginal healing remodeling, improving collagen and function can be done with FDA cleared treatments, including CO2 treatments, such as The MonaLisa Touch therapy, Erbium treatments, and RF treatments such as ThermiVa. Thes treatments can treat sexual pain, increase vaginal tightness, help treat rectoceles and cystoceles, and vulvovaginal disorders such as atrophy. MonaLisa Touch can treat sexual dysfunction it can be used as an isolated therapy or in conjunction with current management strategies for these conditions. Emsella Pelvic Floor strengthening treatment has beneficial effects on urogynecologic symptoms as well, including incontinence, overactive bladder, pelvic floor laxity, and burning. Aisling Chin-Yee, the Canadian filmmaker behind the documentary, is aware of the distinction. “It is super cringey to call it the female Viagra for so many reasons,” she told me. (More reasons: Addyi has to be taken every night, not just when one might want to get busy, can’t be combined with alcohol, and might make you faint.) Starting the film with the comparison, she says, gives viewers a launching-off point to consider the double standards at play in the fight to get Addyi into doctors’ offices and women’s medicine cabinets.

But while the film does explain Addyi’s mechanism of action, framing a female desire drug as the equivalent of a male arousal drug echoes ancient assumptions about the nature of male and female sexuality.

• The pink pill aims to boost women's libido and sexual satisfaction.
• It often contains ingredients like aphrodisiacs or hormonal components.
• Some pink pills are marketed as supplements; others are pharmaceutical drugs.
• Effectiveness varies; consult a healthcare provider before use.

The implication is that for men, sexual problems are all in your penis. But for women, they’re all in your head. If you had a problem with your sex life in the 1950s, you were likely one of two things: impotent or frigid.

Both sounded more like a character flaw than a medical diagnosis. (“Frigidity” goes back to Freud, who first invented the “vaginal orgasm” and then deemed anyone who didn’t achieve it “frigid.”) But you could say the playing field was even. Both male and female sexual problems were “all in your head”—that is, under the purview of psychology. The two branched off in 1992, when the National Institutes of Health replaced the wince-worthy “impotence” with the more respectable “erectile dysfunction,” defined as an inability or difficulty maintaining an erection over a period of six months or more.

• The term "pink pill" is often used metaphorically for gender-specific health solutions.
• Ongoing research aims to develop more effective, safe female libido enhancers.
• Cultural acceptance of such pills varies globally, affecting accessibility.
• Awareness about female sexual health continues to grow, driving demand.

Suddenly, a hard penis was the proxy for healthy male sexuality. While “frigidity” eventually fell out of favor, there was no equivalent effort to replace it. So in 1998, when Viagra’s blockbuster success set off a gold rush for a similar drug for women, researchers ran into a problem: they had no female version of erectile dysfunction to target.

Why did Sprout have to file a separate request to treat decreased libido in women past menopause?

Now, women have the pink pill, Addyi, the first FDA-approved treatment for low female sexual desire. As the film shows, the legacy of Viagra has plagued Addyi from the start. Although Addyi doesn’t work on the genitals, it was reviewed by the FDA’s reproductive and urological drugs division, which also approved Viagra. The FDA required Addyi to show in clinical trials that it increased the number of “satisfying sexual events” a woman had per month, mirroring the requirement that Viagra boost a man’s number of “successful sexual events.” (Successful, in this case, meant that penis was rigid enough to penetrate vagina.) But what made a sexual event satisfying for a woman—she had an orgasm? She ate a cookie afterward?—was never fully defined.

How does Addyi work (mechanism of action)?

“That was asinine,” said Dr. Anita Clayton, a psychiatrist and expert in female sexual problems at the University of Virginia, who worked as a paid consultant for Addyi. “Women will not know what you're talking about. They will not be able to rate this.” While Addyi failed its first two FDA trials, the third showed a modest increase of about one “event” per month, which was deemed significant enough to lead to its approval in 2015. This, for some, was gender parity: “I took on the government for women’s sexual pleasure,” Cindy Eckert, the founder of Sprout Pharmaceuticals, which developed Addyi, says in the film. They tried valiantly to isolate one, using electrodes and infrared cameras to measure arousal factors like vaginal engorgement, blood flow, lubrication, and clitoral erection.

INDICATION AND IMPORTANT SAFETY INFORMATION INCLUDING BOXED WARNING

Wade and rollbacks on birth control access, have changed what health care looks like for women today. The approval and acceptance of Addyi is part of a much larger and ongoing conversation about women’s health and regulatory policy currently. “The past five to 10 years really calls into question where the state of women’s health is going,” Lee said. The Pink Pill: Sex, Drugs & Who Has Control is streaming on Paramount+ in Canada and the U.S. as of March 6, 2026.

How can I get more information about Addyi?

Much research needs to be done on female sex performance, given that reasons for low sex drive in different women, we need to have more than one “pink pill” for women like guys have little blue pill. Addyi was the first approved medicine to improve libido in women. Some women, once libido returns think their arousal is improved, but the medication works on brain centers of desires and shouldn’t really change your physical performance. If your sex isn’t fun, you won’t have libido so we feel it’s important to address the subject of vaginal health. There are many new therapies for female sexual disorders and vaginal disorders which have been FDA Cleared, including MonaLisa Touch CO2 Laser, ThermiVa Radiofrequency treatment, or Emsella chair on sexuality setting. But nothing proved as obvious or easy to measure. Part of the problem was, the split between arousal and desire isn’t quite as neatly defined as the cake analogy would suggest. Arousal is usually thought of as what’s happening in your body in the moment, explains Lori A. Brotto, a psychologist at the University of British Columbia and expert in female sexual problems.

Why do you think sexual desire in women is not treated seriously by the medical community?

These therapies are a well tolerated, almost painless, procedure with few side effects. Indications are also for patients with the urogenital syndrome of menopause or from anti-estrogen therapies. There are also many uses for autologous platelet rich plasma on sexual function, including peri and intraclitoral and g-spot injection treatments which have been shown to enhance sexual function. And now using PGDF for these injections is additionally helpful. Come in to Women’s Health Practice for a consultation.

Drug information

Addyi, otherwise known as the pink pill, might boost your tanked libido, provided it isn’t caused by a medical condition or a less-than-stellar partner. Just as Prozac promises to lift that gray cloud and give you back the pleasure you once took in life, Addyi promises to give you back your appetite for sex. “Desire starts in the brain,” the drug’s website reads. The problem is the media’s insistence on comparing Addyi to another, more well-known pastel-colored pill. “It’s known as Viagra for women,” a newscaster’s voice announces, barely a minute into The Pink Pill: Sex, Drugs & Who Has Control, a documentary that premiered at DOC NYC earlier this month and charts Addyi’s fraught, tortuous journey to FDA approval. But researchers still disagree on how to measure it, and whether it can also include “feelings of mental excitement,” leaving “little agreement about the most intrinsic features of this construct,” three psychologists wrote in 2013.

• Pink pills are part of a broader trend towards female-centered wellness.
• They can potentially enhance intimacy, confidence, and overall satisfaction.
• Unregulated products pose risks of contamination or inappropriate ingredients.
• Always verify product credentials and manufacturer reputation before purchase.

The chief complaint among women is not lack of arousal, but lost desire, according to Dr. Irwin Goldstein, an influential sexual health researcher and paid proponent of both Viagra and Addyi, who also appears in the film. “Most people don’t walk in saying, ‘I don’t swell sufficiently,’” he told me. Critics say that the way it has been defined in the psychological literature—as a lack of sexual fantasies and spontaneous interest in sex—doesn’t reflect how most women experience their sexuality.

• The pink pill can improve blood flow, leading to increased arousal.
• It may help with vaginal dryness or discomfort during intimacy.
• Psychological factors, like stress, also influence its effectiveness.
• Combining with counseling or therapy can enhance results.